Bayer and Soufflé Therapeutics™, an innovative biotech company that discovers and develops cell-selective genetic therapies, today announced a strategic collaboration and global licensing agreement to ...
1don MSN
The 'silent killer' you've probably never heard of — about 85% of people with it are undiagnosed
When it comes to heart health, heart attacks tend to get the spotlight. While 805,000 people die from heart attacks every ...
When it comes to heart health, heart attacks tend to get the spotlight. While 805,000 people die from heart attacks every ...
The U.S. Food and Drug Administration has approved Myqorzo (aficamten) for the treatment of adults with symptomatic ...
People with type 2 diabetes are more likely to develop heart failure, but the reasons are not fully explained by cholesterol, blood pressure and blocked arteries alone. A new study adds another piece ...
Since 2019, three disease-specific therapies have been approved to treat patients with ATTR-CM. The first was Pfizer’s Vyndamax (tafamidis) in May 2019, which was approved for both wild type and ...
These two conditions affect how well your heart can pump blood. Cardiomyopathy can sometimes lead to heart failure. Cardiomyopathy and heart failure are both conditions in which your heart has a more ...
An estimated 85% of people with hypertrophic cardiomyopathy (HCM), the most common inherited heart disease, are reported to be undiagnosed, according to the Heart Failure Society of America.
Social determinants of health (SDOH) were found to be associated with increased risk of heart failure (HF) and ventricular arrhythmias (VA) in patients with hypertrophic cardiomyopathy (HCM), ...
The diagnosis of a potentially lethal cardiovascular disease in a young athlete presents a complex dilemma regarding athlete safety, patient autonomy, team or institutional risk tolerance and medical ...
Scientists develop new blood test to identify individuals at high risk of developing hypertrophic cardiomyopathy, most common ...
Heart failure in which left ventricular ejection fraction recovers into the normal range has many unknowns. Andrew Perry, MD, discusses key management strategies with Jane Wilcox, MD, of Northwestern ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback